Apotex Inc. recalled Bromfenac Ophthalmic Solution 0.09% on August 25, 2015, due to a lack of sterility assurance from failed preservative testing, the FDA said. The recall affects specific lots distributed nationwide.
How to tell if you have it
- Brand: Apotex
- Product: Bromfenac Ophthalmic Solution 0.09%
- NDC 60505-0595-05 (1.7 mL bottle)
- NDC 60505-0596-04 (2.5 mL bottle)
- Lot MF0537, Exp 07/2016
- Lot MF8090, Exp 07/2016
- Lot MF0532, Exp 07/2016
The hazard
The product failed preservative effectiveness testing, resulting in a lack of assurance of sterility. The FDA classified the recall as Class II.
Context
GovInfoNow's records show Apotex Inc. has 19 other recalls on record since April 30, 2012. Other recent recalls include an Apotex Metformin Tablets Recall for NDMA impurity risk on May 27, 2020, and an Apotex Atorvastatin 40mg Tablets Recall for foreign tablets on October 22, 2019. Similar recent recalls of eye drops include an Apotex Brimonidine/Timolol Eye Drops Recall for sterility risk on March 5, 2026, a Clear Eyes Eye Drops Recalled for sterility risk on July 29, 2026, and a K.C. Pharmaceuticals Recalls Eye Drops due to lack of sterility assurance on March 3, 2026.